Ginwa Enterprise Group Inc - Asset Resilience Ratio

Latest as of March 2026: 6.26%

Ginwa Enterprise Group Inc (600080) has an Asset Resilience Ratio of 6.26% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check 600080 strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CN¥122.81 Million

≈ $17.97 Million USD Cash + Short-term Investments

Total Assets

CN¥1.96 Billion

≈ $287.23 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (1994–2025)

This chart shows how Ginwa Enterprise Group Inc's Asset Resilience Ratio has changed over time. See debt-free asset ratio of Ginwa Enterprise Group Inc to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Ginwa Enterprise Group Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Ginwa Enterprise Group Inc market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥122.81 Million	6.26%
Total Liquid Assets	CN¥122.81 Million	6.26%

Asset Resilience Insights

Limited Liquidity: Ginwa Enterprise Group Inc maintains only 6.26% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Ginwa Enterprise Group Inc Industry Peers by Asset Resilience Ratio

Compare Ginwa Enterprise Group Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tonghua Dongbao Pharmaceutical Co Ltd SHG:600867	Drug Manufacturers - Specialty & Generic	0.76%
Eris Lifesciences Limited NSE:ERIS	Drug Manufacturers - Specialty & Generic	0.58%
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	Drug Manufacturers - Specialty & Generic	0.01%
Lotus Pharmaceutical Co Ltd TW:1795	Drug Manufacturers - Specialty & Generic	0.49%
Tasly Pharmaceutical Group Co Ltd SHG:600535	Drug Manufacturers - Specialty & Generic	11.69%
Changzhou Qianhong Biopharma Co Ltd SHE:002550	Drug Manufacturers - Specialty & Generic	18.70%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Sun Pharma Advanced Research Company Limited NSE:SPARC	Drug Manufacturers - Specialty & Generic	0.64%

Annual Asset Resilience Ratio for Ginwa Enterprise Group Inc (1994–2025)

The table below shows the annual Asset Resilience Ratio data for Ginwa Enterprise Group Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	2.56%	CN¥49.28 Million ≈ $7.21 Million	CN¥1.93 Billion ≈ $282.12 Million	+1.29pp
2024-12-31	1.27%	CN¥25.02 Million ≈ $3.66 Million	CN¥1.97 Billion ≈ $288.58 Million	-1.43pp
2023-12-31	2.70%	CN¥56.83 Million ≈ $8.32 Million	CN¥2.11 Billion ≈ $308.55 Million	-4.66pp
2022-12-31	7.35%	CN¥145.14 Million ≈ $21.24 Million	CN¥1.97 Billion ≈ $288.92 Million	-18.86pp
2021-12-31	26.21%	CN¥490.18 Million ≈ $71.73 Million	CN¥1.87 Billion ≈ $273.67 Million	+9.69pp
2020-12-31	16.52%	CN¥323.58 Million ≈ $47.35 Million	CN¥1.96 Billion ≈ $286.60 Million	+12.02pp
2019-12-31	4.50%	CN¥89.18 Million ≈ $13.05 Million	CN¥1.98 Billion ≈ $289.71 Million	+4.41pp
2018-12-31	0.09%	CN¥1.78 Million ≈ $260.12K	CN¥1.97 Billion ≈ $288.98 Million	-0.26pp
2017-12-31	0.35%	CN¥4.93 Million ≈ $720.75K	CN¥1.42 Billion ≈ $207.66 Million	-1.27pp
2016-12-31	1.62%	CN¥23.37 Million ≈ $3.42 Million	CN¥1.44 Billion ≈ $211.30 Million	-1.07pp
2015-12-31	2.69%	CN¥33.78 Million ≈ $4.94 Million	CN¥1.26 Billion ≈ $184.10 Million	-8.72pp
2014-12-31	11.41%	CN¥144.50 Million ≈ $21.14 Million	CN¥1.27 Billion ≈ $185.37 Million	+11.38pp
2005-12-31	0.02%	CN¥525.66K ≈ $76.92K	CN¥2.29 Billion ≈ $334.63 Million	-0.01pp
2004-12-31	0.03%	CN¥567.42K ≈ $83.03K	CN¥1.85 Billion ≈ $271.44 Million	-0.10pp
2003-12-31	0.13%	CN¥1.90 Million ≈ $278.03K	CN¥1.46 Billion ≈ $214.23 Million	0.00pp
2002-12-31	0.13%	CN¥1.74 Million ≈ $255.26K	CN¥1.33 Billion ≈ $195.08 Million	-23.46pp
2000-12-31	23.59%	CN¥244.00 Million ≈ $35.70 Million	CN¥1.03 Billion ≈ $151.37 Million	+12.52pp
1996-12-31	11.07%	CN¥18.00 Million ≈ $2.63 Million	CN¥162.65 Million ≈ $23.80 Million	-1.99pp
1995-12-31	13.05%	CN¥5.20 Million ≈ $760.92K	CN¥39.83 Million ≈ $5.83 Million	+3.71pp
1994-12-31	9.34%	CN¥2.20 Million ≈ $321.93K	CN¥23.54 Million ≈ $3.45 Million	--

pp = percentage points

About Ginwa Enterprise Group Inc

SHG:600080 China Drug Manufacturers - Specialty & Generic

Market Cap

$251.80 Million

CN¥1.72 Billion CNY

Market Cap Rank

#15696 Global

#4580 in China

Share Price

CN¥4.61

Change (1 day)

-3.15%

52-Week Range

CN¥4.61 - CN¥9.16

All Time High

CN¥14.41